362
Participants
Start Date
April 30, 2008
Primary Completion Date
January 31, 2009
Study Completion Date
January 31, 2009
Vardenafil ODT (STAXYN, BAY38-9456)
Subjects will receive 12 weeks of PRN (on demand) treatment with Vardenafil 10mg orodispersible tablet (ODT)
Placebo
Subjects will receive 12 weeks of PRN (on demand) treatment with matching placebo tablet
Bruxelles - Brussel
Bruxelles - Brussel
Bruxelles - Brussel
Krugersdorp
Johannesburg
Antwerp
Johannesburg
Genk
Liège
Durban
Durban
Durban
Cape Town
Cape Town
Ghent
Marseille
Marseille
Hamburg
Hamburg
Vigo
San Cristóbal de La Laguna
Mont-de-Marsan
Mönchengladbach
Mülheim
Valencia
Osnabrück
Lille
Lyon
Lyon
Paris
München
Weiden
Bautzen
Leipzig
Meissen
Arnhem
Deurne
Leiden
Losser
Maastricht
Nijverdal
Centurion
Pretoria
Pretoria
Alicante
Barcelona
Barcelona
Lead Sponsor
Collaborators (2)
GlaxoSmithKline
INDUSTRY
Schering-Plough
INDUSTRY
Bayer
INDUSTRY